Premium
Pseudoporphyria complicating etretinate therapy
Author(s) -
McDONAGH A.J.G.,
HARRINGTON C.I.
Publication year - 1989
Publication title -
clinical and experimental dermatology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.587
H-Index - 78
eISSN - 1365-2230
pISSN - 0307-6938
DOI - 10.1111/j.1365-2230.1989.tb02606.x
Subject(s) - etretinate , medicine , dermatology , psoriasis
Etretinate is recognized to have unwanted cutaneous effects such as dryness of the skin, pruritus and hair thinning. Photosensitivity has rarely been observed as an adverse reaction but we now describe a renal transplant recipient who developed lesions of cutaneous porphyria apparently as a result of etretinate prescribed to suppress cutaneous neoplasia.